[1] de Winter F, Van de Wielec, Dumont F, et al. Biodistribution and dosimetry of 99Tcm-ciprofloxacin, a promising agent for the diagnosis of bacterial infection [J]. Eur J Nucl Med, 2001, 28 (5): 570-574. [2] de Winter F, Gemmel F, Van Laere K,et al. 99Tcm-ciprofloxacin planar and tomographic imaging for the diagnosis of infection in the postoperativespine: experience in 48 patients[J]. Eur J Nucl Med Mol Imaging, 2004, 31(2): 233-239. [3] Walker RC, Jones-Jackson LB, Martin W, et al. New imaging tool for the diagnosis of infection[J]. Future Microbilol, 2007, 2(5): 527-554. [4] Siaens RH, Rennen HJ, Boerman OC, et al. Synthesis and comparison of 99Tcm-enrofloxacin and 99Tcm-ciprofloxacin[J]. J Nucl Med, 2004, 45 (12): 2 088-2 094. [5] Zhang C, Hou GH, Han JK, et al. Radioiodine labeled anti-MIF McAb: a potential agent for inflammation imaging[J]. Mediators Inflamm, 2007, 2007: 50-180.[6] 赵荣, 汪静, 邓敬兰, 等. 99Tcm直接法标记 Octreotide 及其在甲状腺突眼患者的临床初步应用研究[J].中国临床医学影像杂志,2007,18(8):533-536. |